CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) traded down 0.1% during trading on Tuesday . The company traded as low as $94.14 and last traded at $94.18. 5,277 shares changed hands during trading, a decline of 16% from the average session volume of 6,295 shares. The stock had previously closed at $94.25.
Wall Street Analyst Weigh In
CHEOY has been the subject of a number of recent analyst reports. Zacks Research upgraded shares of CochLear to a "hold" rating in a report on Monday, August 11th. UBS Group raised CochLear from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, June 18th. Finally, Citigroup lowered CochLear to a "neutral" rating in a research report on Thursday, September 18th. One research analyst has rated the stock with a Strong Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, CochLear presently has a consensus rating of "Moderate Buy".
View Our Latest Report on CHEOY
CochLear Stock Down 0.1%
The company has a 50-day moving average price of $98.10 and a two-hundred day moving average price of $92.53.
CochLear Dividend Announcement
The business also recently announced a dividend, which will be paid on Tuesday, October 28th. Investors of record on Monday, September 22nd will be issued a dividend of $0.1045 per share. This represents a dividend yield of 122.0%. The ex-dividend date is Friday, September 19th.
CochLear Company Profile
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CochLear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.
While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
